← Browse by Condition
Medical Condition

esophageal varices

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for esophageal varices sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — esophageal varices Clinical Trials

How many clinical trials are currently recruiting for esophageal varices?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for esophageal varices, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for esophageal varices?
esophageal varices research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a esophageal varices clinical trial?
Eligibility criteria for esophageal varices trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Taipei Veterans General Hospital, Taiwan 1 trial
Centre Hospitalier Universitaire, Amiens 1 trial
Shanghai Zhongshan Hospital 1 trial

Recruiting Clinical Trials

NCT06594744 Phase 4
Recruiting
Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCC
Enrollment
120 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
View Trial →
NCT07163689
Recruiting
TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease
Enrollment
360 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06970509
Recruiting
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
Enrollment
1,450 pts
Location
China
Sponsor
Shanghai Zhongshan Hospital
View Trial →

Related Conditions

portal hypertension (2) hepatocellular carcinoma hcc (1) tips (1) porto sinusoidal vascular disease (1) refractory ascite (1) gastrointestinal hemorrhage (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology